BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Oncology News, Insights, Stories by OncoDaily
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20280312T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20281105T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Copenhagen
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20280326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20281029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20290325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20291028T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260417
DTEND;VALUE=DATE:20260419
DTSTAMP:20260418T192749
CREATED:20251228T202535Z
LAST-MODIFIED:20251228T202551Z
UID:10000543-1776384000-1776556799@oncodaily.com
SUMMARY:ESMO Summit Latin America 2026
DESCRIPTION:The ESMO Summit Latin America 2026 is a premier educational meeting scheduled for April 17-18\, 2026\, in Bogotá\, Colombia. \nOrganized by the European Society for Medical Oncology (ESMO) in collaboration with the Colombian Association of Hematology and Oncology (ACHO)\, this two-day summit provides a comprehensive technical review of practice-changing clinical studies and international standards of care. \nThe program is specifically tailored to the regional needs of the Latin American oncology community\, featuring expert-led presentations on key tumor types\, interactive workshops\, and clinical case discussions. Co-chaired by Paula Anel Cabrera-Galeana\, Nadia Harbeck\, and Ray Manneh Kopp\, the event aims to facilitate the integration of the latest oncological breakthroughs into local practice and is typically accredited with ESMO-MORA category-1 CME points. \nRegister.
URL:https://oncodaily.com/event/esmo-summit-latin-america-435283
LOCATION:Hilton Bogota Corferias\, Carrera 37 No. 24 29\, Bogotá\, Bogotá D.C.\, 111321\, Colombia
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO-Latin-America.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260423
DTEND;VALUE=DATE:20260425
DTSTAMP:20260418T192749
CREATED:20260120T145446Z
LAST-MODIFIED:20260120T145452Z
UID:10000603-1776902400-1777075199@oncodaily.com
SUMMARY:ESMO Advanced Course on Early Stage Non-Small-Cell Lung Cancer 2026: Athens
DESCRIPTION:The ESMO Advanced Course on Early Stage Non-Small-Cell Lung Cancer 2026 is an intensive educational meeting scheduled to take place from April 23–24\, 2026\, in Athens\, Greece. \nUnder the leadership of Co-Chairs Helena Linardou\, Giannis Mountzios\, and Solange Peters\, this course is designed to provide oncology professionals with a comprehensive update on the rapidly evolving diagnostic and therapeutic standards for early-stage NSCLC. \nThe program typically emphasizes multidisciplinary management\, covering advancements in neoadjuvant and adjuvant systemic therapies\, surgical innovations\, and the integration of molecular profiling to personalize patient care. Through a combination of expert lectures and interactive discussions\, the event aims to bridge the gap between clinical trial data and real-world practice to improve outcomes for patients with resectable lung cancer. \nApplication.
URL:https://oncodaily.com/event/esmo-advanced-course-444075
LOCATION:Athens\, Greece
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-NSCLC.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260429
DTEND;VALUE=DATE:20260430
DTSTAMP:20260418T192749
CREATED:20260104T000501Z
LAST-MODIFIED:20260104T000515Z
UID:10000545-1777420800-1777507199@oncodaily.com
SUMMARY:ESMO Guidelines: Real World Cases - Webinar Series: Bladder Cancer 2026
DESCRIPTION:The ESMO Guidelines: Real World Cases – Webinar Series: Bladder Cancer 2026 is a specialized virtual scientific meeting scheduled for April 29\, 2026\, focused on translating the latest ESMO Clinical Practice Guidelines into clinical practice. \nChaired by Andrea Necchi\, the webinar addresses the rapidly evolving landscape of bladder cancer management\, including the integration of immune checkpoint inhibitors\, antibody–drug conjugates (ADCs)\, and FGFR-targeted therapies. \nThrough a real-world clinical case analysis presented by experts such as Thomas Powles and Ashish Kamat\, the session provides a technical forum for oncology professionals to discuss treatment sequencing\, patient selection\, and the practical implementation of evidence-based standards. Attendees are eligible for 1 ESMO-MORA category 1 point for participating in this interactive educational event. \nRegister.
URL:https://oncodaily.com/event/esmo-guidelines-436359
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260506
DTEND;VALUE=DATE:20260507
DTSTAMP:20260418T192749
CREATED:20260104T000937Z
LAST-MODIFIED:20260104T000945Z
UID:10000546-1778025600-1778111999@oncodaily.com
SUMMARY:ESMO Deep Dive: Genitourinary Cancers: Improving Outcomes in High-Risk Localized Prostate Cancer 2026
DESCRIPTION:The ESMO Deep Dive: Genitourinary Cancers: Improving Outcomes in High-Risk Localized Prostate Cancer 2026 is a virtual scientific webinar scheduled for May 6\, 2026. \nThis session focuses on the clinical management of high-risk localized prostate cancer\, a disease state associated with significant risks of recurrence and mortality. Chaired by Deborah Mukherji\, the program features technical discussions led by experts including Stephen Freedland\, Christopher Sweeney\, and Derya Tilki. \nKey topics include advanced risk stratification\, the role of systemic therapies in combination with radiotherapy\, and evidence-based strategies for managing biochemical recurrence. The webinar aims to provide oncology professionals with updated knowledge to individualize treatment approaches and improve long-term outcomes\, awarding 2 ESMO-MORA category 1 points to live participants. \nRegister.
URL:https://oncodaily.com/event/esmo-deep-dive-436363
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-Deep-Dive.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20260506T080000
DTEND;TZID=Europe/Berlin:20260508T170000
DTSTAMP:20260418T192749
CREATED:20250712T062036Z
LAST-MODIFIED:20250712T062110Z
UID:10000212-1778054400-1778259600@oncodaily.com
SUMMARY:The ESMO Breast Cancer 2026
DESCRIPTION:Join the global breast cancer community at ESMO Breast Cancer 2026\, taking place from 6 to 8 May 2026 in Berlin\, Germany\, or online. \nThis international congress will gather top experts\, researchers\, and clinicians to explore the latest advances in breast cancer care\, covering everything from early detection to innovative treatments and survivorship strategies. \nThe event offers a platform to engage with global leaders\, share real-world insights\, and help shape the future of breast cancer treatment. The Scientific Committee is co-chaired by Masakazu Toi\, Sara Tolaney and Nicholas Turner.
URL:https://oncodaily.com/event/esmo-327164
LOCATION:Messe Berlin\, Messedamm 22\, Berlin\, 14055\, Germany
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/07/IMG_7076.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260511
DTEND;VALUE=DATE:20260513
DTSTAMP:20260418T192749
CREATED:20260104T001332Z
LAST-MODIFIED:20260104T001344Z
UID:10000547-1778457600-1778630399@oncodaily.com
SUMMARY:ESMO Preceptorship on Hereditary Cancer Genetics 2026: Lugano
DESCRIPTION:The ESMO Preceptorship on Hereditary Cancer Genetics 2026 is an intensive educational course scheduled for May 11–12\, 2026\, in Lugano\, Switzerland. \nCo-chaired by Judith Balmaña and Marjolijn Ligtenberg\, this program is designed to provide oncologists with a comprehensive understanding of the molecular basis of genetic susceptibility to cancer. The technical curriculum focuses on the multidisciplinary management of hereditary cancer syndromes\, the identification and diagnosis of germline genetic mutations\, and the implementation of evidence-based prevention strategies. \nThrough a combination of state-of-the-art lectures and interactive clinical case discussions\, the course aims to equip participants with the skills necessary to provide personalized care for patients with hereditary cancer risks. Successful applicants benefit from complimentary registration and accommodation\, and the event is accredited with 9 ESMO-MORA category 1 points. \nApplication.
URL:https://oncodaily.com/event/hereditary-cancer-genetics-436366
LOCATION:Lugano\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-Preceptorship.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260513
DTEND;VALUE=DATE:20260515
DTSTAMP:20260418T192749
CREATED:20260104T001901Z
LAST-MODIFIED:20260104T001917Z
UID:10000548-1778630400-1778803199@oncodaily.com
SUMMARY:ESMO Preceptorship on Head and Neck Cancer 2026: Lugano
DESCRIPTION:The ESMO Preceptorship on Head and Neck Cancer 2026 is a specialized educational course scheduled for May 13–14\, 2026\, in Lugano\, Switzerland. \nThis program is designed to provide medical and clinical oncologists with a deep understanding of the management of head and neck cancers\, ranging from diagnosis to advanced treatment strategies. The curriculum covers the epidemiology\, etiology\, and molecular biology of nasopharyngeal cancer (NPC) and head and neck squamous cell carcinoma (HNSCC). \nParticipants will explore multidisciplinary management approaches\, including the roles of surgery\, radiation therapy\, and systemic therapy\, with a particular emphasis on the integration of immunotherapy and the management of rare tumors. The course combines plenary lectures with interactive\, case-based sessions to facilitate direct engagement between participants and international experts. Successful applicants receive complimentary registration and accommodation\, and the event is accredited with 11 ESMO-MORA category 1 points. \nApplication.
URL:https://oncodaily.com/event/head-and-neck-cancer-436369
LOCATION:Lugano\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-Preceptorship-on-Head-and-Neck-Cancer.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260515
DTEND;VALUE=DATE:20260517
DTSTAMP:20260418T192749
CREATED:20260104T234351Z
LAST-MODIFIED:20260104T234406Z
UID:10000549-1778803200-1778975999@oncodaily.com
SUMMARY:ESMO Preceptorship on Colorectal Cancer 2026: Lugano
DESCRIPTION:The ESMO Preceptorship on Colorectal Cancer 2026: Lugano is a specialized educational course scheduled for May 15–16\, 2026\, in Lugano\, Switzerland. \nThis course is designed to provide oncologists – particularly young and general oncologists – with a comprehensive understanding of colorectal cancer management from diagnosis to treatment. The technical program includes plenary lectures by international experts and interactive case-based sessions\, covering best practices in multidisciplinary management for both adjuvant and metastatic settings\, the role of molecular pathology in prognosis\, and the optimal sequencing of systemic therapies. \nSuccessful applicants benefit from complimentary registration and accommodation\, and the event is accredited with 9 ESMO-MORA category 1 points. \nApplication.
URL:https://oncodaily.com/event/colorectal-cancer-2026-436774
LOCATION:Lugano\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-Preceptorship-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260520
DTEND;VALUE=DATE:20260521
DTSTAMP:20260418T192749
CREATED:20260104T234810Z
LAST-MODIFIED:20260104T234817Z
UID:10000550-1779235200-1779321599@oncodaily.com
SUMMARY:ESMO Guidelines: Real World Cases Webinar: Metastatic Breast Cancer 2026
DESCRIPTION:The ESMO Guidelines: Real World Cases Webinar: Metastatic Breast Cancer 2026 is a virtual scientific webinar\, scheduled for May 20\, 2026\, that focuses on the practical application of ESMO Clinical Practice Guidelines (CPG) in the management of metastatic breast cancer (MBC). \nChaired by Evandro de Azambuja\, the program features a real-world case presentation by Ana Tecic Vuger\, followed by a critical analysis of the current guidelines by Seock-Ah Im. A multidisciplinary panel\, including experts Nadia Harbeck and Giuseppe Curigliano\, will discuss therapeutic sequencing\, decision-making in advanced disease\, and strategies for overcoming implementation challenges in daily clinical practice. The session provides oncology professionals with 1 ESMO-MORA category 1 point. \nRegister.
URL:https://oncodaily.com/event/esmo-guidelines-436778
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-Guidelines-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260610
DTEND;VALUE=DATE:20260612
DTSTAMP:20260418T192749
CREATED:20260120T150034Z
LAST-MODIFIED:20260120T150042Z
UID:10000604-1781049600-1781222399@oncodaily.com
SUMMARY:ESMO Preceptorship on Neuroendocrine Neoplasms (NENs) 2026: Hong Kong SAR
DESCRIPTION:The ESMO Preceptorship on Neuroendocrine Neoplasms (NENs) 2026 is a specialized educational meeting scheduled to take place from June 10–11\, 2026\, in Hong Kong SAR\, China. Co-chaired by Nicola Fazio and David Tai\, this course is designed to provide oncology professionals with a thorough grounding in the multidisciplinary management of neuroendocrine tumors\, ranging from diagnosis to advanced therapeutic strategies. \nThe program typically emphasizes the integration of clinical guidelines into practical patient care\, covering the latest developments in pathology\, imaging\, and systemic treatments\, including peptide receptor radionuclide therapy (PRRT). Through expert-led lectures and clinical case discussions\, the preceptorship aims to enhance the clinical expertise of participants and foster international collaboration in the field of rare tumor management. \nApplication.
URL:https://oncodaily.com/event/neuroendocrine-neoplasms-444081
LOCATION:Hong Kong SAR\, China
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-NET-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260612
DTEND;VALUE=DATE:20260615
DTSTAMP:20260418T192749
CREATED:20251126T125513Z
LAST-MODIFIED:20251126T125537Z
UID:10000409-1781222400-1781481599@oncodaily.com
SUMMARY:ESMO Targeted Anticancer Therapies Asia Congress 2026
DESCRIPTION:The ESMO Targeted Anticancer Therapies Asia Congress 2026 will be a three-day event dedicated to advancing cancer drug discovery and precision oncology in the Asia-Pacific region. \n\nDates: June 12–14\, 2026\nLocation: Kerry Hotel\, Hong Kong SAR\, China\nAbstract Submission Deadline: March 31\, 2026\n\nThis congress serves as a key platform for researchers\, industry leaders\, and clinicians to share the latest advances in early-phase drug development and targeted therapies. \nAbstract Submission.
URL:https://oncodaily.com/event/targeted-anticancer-therapies-416778
LOCATION:Kerry Hotel\, Hong Kong\, 38 Hung Luen Road\, Hung Hom Bay\, Kowloon\, China
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/ESMO-TAT-Asia-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260613
DTEND;VALUE=DATE:20260619
DTSTAMP:20260418T192749
CREATED:20251203T225231Z
LAST-MODIFIED:20251203T225243Z
UID:10000439-1781308800-1781827199@oncodaily.com
SUMMARY:26th Workshop on Methods in Clinical Cancer Research
DESCRIPTION:The 26th Workshop on Methods in Clinical Cancer Research (MCCR workshop) is a prestigious professional development event for oncology researchers\, taking place from June 13–18\, 2026\, in Sint Michielsgestel\, Netherlands. \nOrganized in collaboration by the European Organisation for Research and Treatment of Cancer (EORTC)\, the European Society for Medical Oncology (ESMO)\, and the American Association for Cancer Research (AACR)\, applications are currently open to participate in this highly-regarded course\, which aims to provide comprehensive training on the design and conduct of successful clinical cancer research trials. \nApply.
URL:https://oncodaily.com/event/clinical-cancer-research-421180
LOCATION:De Ruwenberg Hotel\, Ruwenbergstraat 7\, Sint-Michielsgestel\, 5271 AG\, Netherlands
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/BeFunky-collage-2025-12-02T101638863-Picsart-AiImageEnhancer.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Copenhagen:20260617T080000
DTEND;TZID=Europe/Copenhagen:20260619T170000
DTSTAMP:20260418T192749
CREATED:20250714T223214Z
LAST-MODIFIED:20250714T223246Z
UID:10000215-1781683200-1781888400@oncodaily.com
SUMMARY:The ESMO Gynaecological Cancers Congress 2026
DESCRIPTION:The ESMO Gynaecological Cancers Congress 2026 will take place from 17–19 June in Copenhagen\, Denmark\, as well as online.  \nThis global event brings together experts\, researchers\, and healthcare professionals to explore the latest advancements in the diagnosis and treatment of ovarian\, cervical\, uterine\, vaginal\, and vulvar cancers. The programme features keynote lectures\, interactive sessions\, and dynamic discussions designed to promote collaboration and accelerate progress in gynaecological oncology. \nWith a strong emphasis on supporting young oncology professionals\, the congress offers opportunities for early-career specialists to present their research\, gain recognition\, and connect with mentors. Scientific Co-Chairs Nicoletta Colombo\, Kosei Hasegawa and Ana Oaknin from Barcelona lead the event\, ensuring a comprehensive and impactful experience for all participants. \nRead More Posts Featuring ESMO at OncoDaily.com.
URL:https://oncodaily.com/event/esmo-329239
LOCATION:Bella Center\, Center Boulevard 5\, Copenhagen\, 2300\, Denmark
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/07/IMG_7173.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260624
DTEND;VALUE=DATE:20260625
DTSTAMP:20260418T192749
CREATED:20260104T235612Z
LAST-MODIFIED:20260104T235618Z
UID:10000551-1782259200-1782345599@oncodaily.com
SUMMARY:ESMO Guidelines: Real World Cases - Webinar Series: Cervical Cancer 2026
DESCRIPTION:The ESMO Guidelines: Real World Cases – Webinar Series: Cervical Cancer 2026 is a virtual scientific session scheduled for June 24\, 2026. \nChaired by Ana Oaknin\, the webinar is designed to help oncology professionals translate the latest ESMO Clinical Practice Guidelines (CPG) into daily clinical practice. The program includes a real-world case presentation by Avinash Ramchandani Vaswani\, a critical analysis of the guidelines by Domenica Lorusso\, and a discussion on implementation barriers by Benedetta Pellegrino. \nKey technical topics include the integration of immune checkpoint inhibitors and anti-angiogenic agents for advanced and recurrent disease\, as well as strategies for multidisciplinary collaboration and equitable access to care. Live participants are eligible for 1 ESMO-MORA category 1 point. \nRegister.
URL:https://oncodaily.com/event/esmo-guidelines-436781
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-Guidelines-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260626
DTEND;VALUE=DATE:20260628
DTSTAMP:20260418T192749
CREATED:20260120T150529Z
LAST-MODIFIED:20260120T150555Z
UID:10000605-1782432000-1782604799@oncodaily.com
SUMMARY:ESMO Preceptorship on Gastric Cancer 2026: Lisbon
DESCRIPTION:The ESMO Preceptorship on Gastric Cancer 2026 is a specialized educational event scheduled to take place in Lisbon\, Portugal\, from June 26–27\, 2026. Co-chaired by Tania Fleitas and Hanneke van Laarhoven\, this multidisciplinary course is designed to provide oncology professionals with an in-depth understanding of the current standards and emerging therapies for gastric and gastroesophageal junction cancers. \nThe program emphasizes the practical application of evidence-based medicine through expert-led lectures and clinical case discussions\, covering the entire patient journey from early diagnosis and molecular screening to surgical innovations and advanced systemic treatments like immunotherapy. \nApplication.
URL:https://oncodaily.com/event/gastric-cancer-444088
LOCATION:Lisbon\, Portugal
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-GC-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260701
DTEND;VALUE=DATE:20260702
DTSTAMP:20260418T192749
CREATED:20260128T212652Z
LAST-MODIFIED:20260128T212701Z
UID:10000639-1782864000-1782950399@oncodaily.com
SUMMARY:ESMO Deep Dive: Genitourinary Cancers: Metastatic Castration-Resistant Prostate Cancer 2026
DESCRIPTION:The ESMO Deep Dive: Genitourinary Cancers: Metastatic Castration-Resistant Prostate Cancer 2026 is a virtual webinar scheduled for July 1\, 2026\, at 18:30 CEST. \nChaired by Aurelius Gabriel Omlin\, the session focuses on advanced management strategies for mCRPC\, including treatment sequencing\, the potential role of immunotherapy\, and the optimization of patient selection for radioligand therapy. \nThe program features expert presentations from Gunhild Von Amsberg\, Alice Bernard-Tessier\, and Karolien Goffin\, followed by a panel discussion to evaluate clinical data and address remaining unmet needs in the field. This educational activity is available to ESMO members and offers 2 ESMO-MORA category 1 points for live viewers. \nRegister.
URL:https://oncodaily.com/event/esmo-deep-dive-448592
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-Deep-Dive.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260701
DTEND;VALUE=DATE:20260703
DTSTAMP:20260418T192749
CREATED:20260120T151018Z
LAST-MODIFIED:20260120T151027Z
UID:10000606-1782864000-1783036799@oncodaily.com
SUMMARY:ESMO Preceptorship on Endometrial Cancer 2026: Lugano
DESCRIPTION:The ESMO Preceptorship on Endometrial Cancer 2026 is a specialized educational course scheduled for July 1–2\, 2026\, in Lugano\, Switzerland. \nThis intensive program is designed to provide medical oncologists with a comprehensive understanding of the multidisciplinary management of endometrial cancer\, from diagnosis and pathology to advanced therapeutic strategies. Key learning objectives typically include exploring the “new” FIGO staging\, the role of molecular classification in tailoring treatment\, and the revolutionary impact of immunotherapy and combination therapies in recurrent or metastatic disease. \nApplication.
URL:https://oncodaily.com/event/endometrial-cancer-444093
LOCATION:Lugano\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-Lugano-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260701T000000
DTEND;TZID=America/Halifax:20260704T000000
DTSTAMP:20260418T192749
CREATED:20250714T223034Z
LAST-MODIFIED:20250714T223049Z
UID:10000216-1782864000-1783123200@oncodaily.com
SUMMARY:The ESMO Gastrointestinal Cancers Congress 2026
DESCRIPTION:The ESMO Gastrointestinal Cancers Congress 2026 will be held from 1 to 4 July in Munich\, Germany\, and online. \nThis major event brings together global experts\, researchers\, and healthcare professionals focused on improving prevention\, diagnosis\, and treatment across the full spectrum of gastrointestinal cancers. \nWith a programme featuring expert-led discussions\, tumour boards\, clinical debates\, and presentations of the latest research\, participants will gain practical insights and updates on GI oncology. The congress is designed to promote collaboration and knowledge exchange\, offering opportunities to engage with peers and help shape the future of gastrointestinal cancer care. \nRead More Posts Featuring ESMO at OncoDaily.com.
URL:https://oncodaily.com/event/esmo-329242
LOCATION:Munich\, Germany\, Munich\, Germany
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/07/IMG_7175.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260708
DTEND;VALUE=DATE:20260710
DTSTAMP:20260418T192749
CREATED:20260128T212311Z
LAST-MODIFIED:20260128T212317Z
UID:10000638-1783468800-1783641599@oncodaily.com
SUMMARY:ESMO Preceptorship on Endocrine Tumours 2026: Lugano
DESCRIPTION:The ESMO Preceptorship on Endocrine Tumours 2026: Lugano is scheduled for July 8–9\, 2026\, in Lugano\, Switzerland. Co-chaired by Alfredo Berruti and Rocio Garcia-Carbonero\, this intensive educational course is designed to provide medical oncologists with a comprehensive understanding of the multidisciplinary management of endocrine neoplasms. \nThe curriculum typically focuses on the latest standards of care\, molecular pathology\, and evolving therapeutic strategies\, aiming to bridge the gap between research and clinical practice. Successful applicants benefit from complimentary registration and accommodation while participating in interactive case-based sessions and networking with international experts in the field. \nApplication.
URL:https://oncodaily.com/event/esmo-preceptorship-448586
LOCATION:Lugano\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-9.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260724
DTEND;VALUE=DATE:20260729
DTSTAMP:20260418T192749
CREATED:20251107T221919Z
LAST-MODIFIED:20251107T221936Z
UID:10000328-1784851200-1785283199@oncodaily.com
SUMMARY:ESMO Course in Medical Oncology for Medical Students 2026
DESCRIPTION:The ESMO Course in Medical Oncology for Medical Students 2026 is an interactive\, four-day residential educational program taking place from July 24 to 28\, 2026\, in Valencia\, Spain. Organized by the European Society for Medical Oncology (ESMO)\, the course is specifically designed for fourth and fifth-year medical students. Co-Chaired by Andrés Cervantes and Rodrigo Sanchez Bayona (Spain)\, the course provides a high-standard\, interactive educational program—including state-of-the-art lectures\, clinical case discussions\, and dedicated workshops—with the primary goal of providing insight into the field of medical oncology and motivating students to commit to this fast-evolving specialty.
URL:https://oncodaily.com/event/esmo-course-404879
LOCATION:INCLIVA Biomedical Research Institute\, C. de Menéndez y Pelayo\, 4\, Valencia\, 46010\, Spain
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/11/esmo.png
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260910
DTEND;VALUE=DATE:20260912
DTSTAMP:20260418T192749
CREATED:20251126T131341Z
LAST-MODIFIED:20251126T131416Z
UID:10000410-1788998400-1789171199@oncodaily.com
SUMMARY:Molecular Analysis for Precision Oncology Congress 2026
DESCRIPTION:The Molecular Analysis for Precision Oncology (MAP) Congress 2026\, co-organized by the European Society for Medical Oncology (ESMO)\, Cancer Research UK (CRUK)\, and Unicancer\, is scheduled for 10–11 September 2026 in London\, United Kingdom. \nThis high-level\, two-day meeting will serve as a platform for experts in oncology\, molecular diagnostics\, and precision medicine to converge and exchange ideas. \nThe primary focus of the congress is to share advances in cancer research\, strengthen interdisciplinary connections\, and accelerate the translation of molecular insights – particularly concerning molecular profiling\, biomarker discovery\, and personalized treatment strategies – into routine clinical practice to improve global patient care.
URL:https://oncodaily.com/event/precision-oncology-416782
LOCATION:London\, United Kingdom
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/MAP2026.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260918
DTEND;VALUE=DATE:20260920
DTSTAMP:20260418T192749
CREATED:20260126T222113Z
LAST-MODIFIED:20260126T222126Z
UID:10000627-1789689600-1789862399@oncodaily.com
SUMMARY:ESMO Preceptorship on Tumour-agnostic and Cancer of Unknown Primary 2026: Zurich
DESCRIPTION:The ESMO Preceptorship on Tumour-agnostic and Cancer of Unknown Primary 2026 is scheduled to take place in Zurich\, Switzerland\, from September 18–19\, 2026. \nChaired by Natalie Cook and Benedikt Westphalen\, this educational course aims to provide oncologists with a comprehensive understanding of the management of these complex diseases\, from diagnosis to treatment\, according to current standards of care. \nThe program focuses on the reshaping of cancer care through tumour-agnostic therapies andprecision oncology\, offering participants the opportunity to learn from leaders in the field while earning 10 ESMO-MORA category 1 points. Applications for the course open with a deadline of June 3\, 2026\, and successful applicants benefit from complimentary registration and accommodation.
URL:https://oncodaily.com/event/esmo-preceptorship-447566
LOCATION:Zurich\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-1-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260930
DTEND;VALUE=DATE:20261001
DTSTAMP:20260418T192749
CREATED:20260127T204408Z
LAST-MODIFIED:20260127T204424Z
UID:10000636-1790726400-1790812799@oncodaily.com
SUMMARY:ESMO Guidelines: Real World Cases - Webinar Series: Uveal Melanoma 2026
DESCRIPTION:The ESMO Guidelines: Real World Cases – Webinar Series: Uveal Melanoma 2026 is scheduled for Wednesday\, September 30\, 2026\, starting at 18:30 CEST. \nAs uveal melanoma remains a rare and biologically distinct entity from cutaneous melanoma\, this webinar provides a critical platform for presenting evidence-based recommendations from the ESMO Clinical Practice Guidelines through the lens of daily practice. \nChaired by Olivier Michielin\, the session features a multidisciplinary expert panel including Jorja Braden\, Sophie Piperno-Neumann\, Erick Saldanha\, and Mauricio Fernando Silva Almeida Ribeiro. The program focuses on translating recent breakthroughs – such as the efficacy of tebentafusp – into practical clinical strategies\, addressing implementation barriers\, and utilizing molecular profiling to optimize patient management. \nRegister.
URL:https://oncodaily.com/event/esmo-guidelines-448014
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-Guidelines-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261023
DTEND;VALUE=DATE:20280205
DTSTAMP:20260418T192749
CREATED:20250715T190605Z
LAST-MODIFIED:20260127T204055Z
UID:10000218-1792742400-1833296400@oncodaily.com
SUMMARY:The ESMO Congress 2026
DESCRIPTION:The ESMO Congress 2026 will take place from 23–27 October in Madrid\, Spain\, bringing together oncology professionals from around the world. \nThis global event serves as a key platform for presenting groundbreaking research\, advancing clinical practice\, and shaping patient care in oncology. Attendees can expect new data releases\, interactive educational sessions\, networking opportunities\, and an innovative exhibition area. \nLed by Congress President Fabrice André\, along with Scientific Co-Chairs Yelena Janjigian and James Larkin\, and Educational Chair Nadia Harbeck\, the congress will cover the latest developments across all areas of cancer care. By joining ESMO 2026\, participants contribute to global progress in oncology while staying up to date with the most relevant clinical and research advancements. \nRead More Posts Featuring ESMO at OncoDaily.com.
URL:https://oncodaily.com/event/esmo-329848
LOCATION:Madrid\, Madrid\, Spain
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/07/IMG_7216.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261111
DTEND;VALUE=DATE:20261113
DTSTAMP:20260418T192749
CREATED:20260127T203943Z
LAST-MODIFIED:20260127T203943Z
UID:10000635-1794355200-1794527999@oncodaily.com
SUMMARY:ESMO Advanced Course on Brain Metastases in Lung and Breast Cancer 2026: Barcelona
DESCRIPTION:The ESMO Advanced Course on Brain Metastases in Lung and Breast Cancer 2026: Barcelona is scheduled to take place in Barcelona\, Spain\, from November 11–12\, 2026. \nThis specialized educational program is co-chaired by Simon Ekman\, Lizza Hendriks\, and Natasha Leighl\, and focuses on providing oncologists with high-level training on the evolving diagnostic and therapeutic strategies for brain metastases originating from lung and breast malignancies. The course is designed to address the clinical challenges of managing central nervous system involvement\, highlighting the latest research\, systemic therapies\, and multidisciplinary approaches essential for optimizing patient outcomes in these complex cases. \nApplication.
URL:https://oncodaily.com/event/brain-metastases-448007
LOCATION:Barcelona\, Spain
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-8.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261116
DTEND;VALUE=DATE:20261119
DTSTAMP:20260418T192749
CREATED:20251127T193756Z
LAST-MODIFIED:20251127T193815Z
UID:10000412-1794787200-1795046399@oncodaily.com
SUMMARY:ESMO AI and Digital Oncology Congress 2026
DESCRIPTION:The ESMO AI and Digital Oncology Congress 2026 will take place from November 16-18\, 2026\, in Berlin\, Germany. \nThis congress is designed as a central meeting point that facilitates the exchange of the latest research\, promotes ethical dialogue\, and highlights technological innovation in cancer care. \nIt brings together healthcare and digital health experts from around the world to foster collaboration\, inspire learning\, and empower oncology professionals to stay ahead in the rapidly evolving digital transformation of medicine. \nThe specific congress venue within Berlin is expected to be announced on the official European Society for Medical Oncology (ESMO) website closer to the event date.
URL:https://oncodaily.com/event/esmo-417477
LOCATION:Berlin\, Germany
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/ESMO-2.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261204
DTEND;VALUE=DATE:20261207
DTSTAMP:20260418T192749
CREATED:20260105T000502Z
LAST-MODIFIED:20260105T000508Z
UID:10000552-1796342400-1796601599@oncodaily.com
SUMMARY:ESMO Asia Congress 2026
DESCRIPTION:The ESMO Asia Congress 2026 is the premier scientific platform in the Asia-Pacific region for oncology professionals\, scheduled for December 4-6\, 2026\, in Singapore. \nOrganized by the European Society for Medical Oncology (ESMO)\, this major international congress brings together global experts and regional leaders to present the latest research and clinical data across all major tumor types. \nThe technical program features high-level scientific symposia\, educational sessions on state-of-the-art treatments\, and a dedicated Young Oncologists track aimed at fostering the next generation of cancer researchers. The event emphasizes regional specificities in cancer management and promotes collaborative research to improve patient outcomes throughout Asia.
URL:https://oncodaily.com/event/esmo-asia-436785
LOCATION:Suntec Singapore Convention & Exhibition Centre\, 1 Raffles Boulevard Singapore\, Singapore\, 039593\, Singapore
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-Asia-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261214
DTEND;VALUE=DATE:20261217
DTSTAMP:20260418T192749
CREATED:20251211T193956Z
LAST-MODIFIED:20251211T194040Z
UID:10000476-1797206400-1797465599@oncodaily.com
SUMMARY:ESMO Immuno-Oncology Congress 2026
DESCRIPTION:The ESMO Immuno-Oncology Congress 2026 is a premier international event hosted by the European Society for Medical Oncology (ESMO)\, scheduled for December 14–16\, 2026\, as an onsite event in London\, United Kingdom\, with an online option also available. \nThe congress serves as a critical platform for exchanging knowledge and fostering collaboration in immuno-oncology\, covering the entire spectrum of the field from basic science to translational research and clinical development. The meeting will feature the latest scientific advances\, offering researchers\, clinicians\, and other stakeholders excellent opportunities to interact\, share expertise\, and engage with the global community committed to advancing cancer care through innovation.
URL:https://oncodaily.com/event/immuno-oncology-426416
LOCATION:London\, United Kingdom
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO-IO-2026.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270917
DTEND;VALUE=DATE:20270922
DTSTAMP:20260418T192749
CREATED:20251127T194612Z
LAST-MODIFIED:20251127T194628Z
UID:10000413-1821139200-1821571199@oncodaily.com
SUMMARY:ESMO Congress 2027
DESCRIPTION:The ESMO Congress 2027 will take place in Barcelona\, Spain\, from September 17–21\, 2027. \nThis event is recognized as a leading global oncology meeting that serves as a platform for progress by showcasing the latest breakthroughs in oncology research\, clinical practice\, and patient care. The congress brings together a diverse community\, including clinicians\, researchers\, patient advocates\, journalists\, and healthcare industry representatives. \nParticipants can anticipate a dynamic program featuring: \n\nImpactful new data from oncology research.\nInteractive educational sessions.\nUnique networking opportunities.\nA dynamic exhibition area.\n\nBy attending\, participants will gain first-hand insights into the most recent advances and contribute to shaping the future of oncology worldwide.
URL:https://oncodaily.com/event/esmo-congress-2027-417485
LOCATION:Barcelona\, Spain
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/16_9-1-2.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
END:VCALENDAR